1. Home
  2. PLSE vs STVN Comparison

PLSE vs STVN Comparison

Compare PLSE & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

N/A

Current Price

$52.32

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

N/A

Current Price

$15.78

Market Cap

3.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
PLSE
STVN
Founded
2014
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.9B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
PLSE
STVN
Price
$52.32
$15.78
Analyst Decision
Strong Buy
Buy
Analyst Count
6
13
Target Price
★ $67.67
$19.46
AVG Volume (30 Days)
362.6K
★ 1.2M
Earning Date
11-05-2026
11-03-2026
Dividend Yield
N/A
★ 0.38%
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$480.71
$6.90
Revenue Next Year
$177.98
$2.38
P/E Ratio
★ N/A
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$12.56
$12.05
52 Week High
$58.94
$24.01

Technical Indicators

Market Signals
Indicator
PLSE
STVN
Relative Strength Index (RSI) 49.27 42.52
Support Level $49.66 $13.12
Resistance Level $56.54 $17.19
Average True Range (ATR) 4.03 1.10
MACD -0.08 -0.15
Stochastic Oscillator 24.10 42.74

Price Performance

Historical Comparison
PLSE
STVN

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

About STVN Stevanato Group S.p.A.

Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.

Share on Social Networks: